Novo Nordisk Warns of Continued Ozempic Shortage in Q4
Novo Nordisk's Says Ozempic Shortage Deteriorates. Why It's Good News For Eli Lilly.
Can the "weight loss miracle drug" from Novo Nordisk reduce the mortality rate of COVID-19 and bring more surprises?
The latest research found that people who took semaglutide have a 33% lower risk of death after being infected with COVID-19 compared to those who did not take it; Semaglutide not only reduces the risk of heart disease, but also has other benefits, such as improving symptoms of heart failure, inflammation, and reducing the mortality rate of patients with chronic kidney disease.
Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate
Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential
Weight-Loss Drugs' Promise And Pitfalls -- Barron's
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
MonkeyGee : if you need a pill to lose weight, you have other issues.
Learning_Piggy : I used to think this way until I looked around and see more than a few obese people never managed to get out of obesity by themselves.
With or without surgery, with or without dietary restriction, obesity will most likely come back to them and it takes more than just personal grit to fight it.
InfiltradeR Learning_Piggy : Let's not forget the ever rising diabetes numbers.